PortfoliosLab logoPortfoliosLab logo
FTXH vs. BBC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. BBC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTXH achieves a 7.62% return, which is significantly lower than BBC's 11.41% return.


FTXH

1D
2.50%
1M
3.66%
YTD
7.62%
6M
9.20%
1Y
39.54%
3Y*
12.33%
5Y*
8.33%
10Y*

BBC

1D
2.55%
1M
-4.36%
YTD
11.41%
6M
14.39%
1Y
123.10%
3Y*
20.63%
5Y*
-1.47%
10Y*
7.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. BBC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTXH
First Trust Nasdaq Pharmaceuticals ETF
7.62%24.15%2.98%-1.41%2.55%6.14%11.73%22.13%-9.51%19.44%
BBC
Virtus LifeSci Biotech Clinical Trials ETF
11.41%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%

Correlation

The correlation between FTXH and BBC is 0.56, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.56

Correlation (3Y)
Calculated over the trailing 3-year period

0.56

Correlation (5Y)
Calculated over the trailing 5-year period

0.55

Correlation (All Time)
Calculated using the full available price history since Sep 23, 2016

0.54

The correlation between FTXH and BBC has been stable across timeframes, ranging from 0.54 to 0.56 - a consistent structural relationship.

FTXH vs. BBC - Sectors Allocation Comparison


Sectors
FTXH
BBC

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

FTXH
100.0%
BBC
100.0%

Basic Materials

FTXH

-

BBC

-

Communication Services

FTXH

-

BBC

-

Consumer Cyclical

FTXH

-

BBC

-

Consumer Defensive

FTXH

-

BBC

-

Energy

FTXH

-

BBC

-

Financial Services

FTXH

-

BBC

-

Industrials

FTXH

-

BBC

-

Real Estate

FTXH

-

BBC

-

Technology

FTXH

-

BBC

-

Utilities

FTXH

-

BBC

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. BBC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH
FTXH Risk / Return Rank: 7777
Overall Rank
FTXH Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 7777
Sortino Ratio Rank
FTXH Omega Ratio Rank: 6767
Omega Ratio Rank
FTXH Calmar Ratio Rank: 8989
Calmar Ratio Rank
FTXH Martin Ratio Rank: 8080
Martin Ratio Rank

BBC
BBC Risk / Return Rank: 9191
Overall Rank
BBC Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 9090
Sortino Ratio Rank
BBC Omega Ratio Rank: 8181
Omega Ratio Rank
BBC Calmar Ratio Rank: 9595
Calmar Ratio Rank
BBC Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. BBC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FTXHBBCDifference
Sharpe ratioReturn per unit of total volatility

-1.18

Sortino ratioReturn per unit of downside risk

-0.72

Omega ratioGain probability vs. loss probability

1.39

1.48

-0.09

Calmar ratioReturn relative to maximum drawdown

5.32

8.20

-2.88

Martin ratioReturn relative to average drawdown

15.35

25.91

-10.56

FTXH vs. BBC - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.32, which is lower than the BBC Sharpe Ratio of 3.49. The chart below compares the historical Sharpe Ratios of FTXH and BBC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


FTXHBBCDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.32

3.49

-1.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.51

-0.04

+0.55

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.21

Sharpe Ratio (All Time)

Calculated using the full available price history

0.39

0.12

+0.27

Drawdowns

FTXH vs. BBC - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for FTXH and BBC.


Loading charts...

Drawdown Indicators


FTXHBBCDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-76.85%

+44.74%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

-15.10%

+7.63%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

-54.45%

+34.94%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

-72.44%

+52.93%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

Current Drawdown

Current decline from peak

-0.45%

-28.49%

+28.04%

Average Drawdown

Average peak-to-trough decline

-5.84%

-37.13%

+31.29%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.58%

4.77%

-2.19%

Volatility

FTXH vs. BBC - Volatility Comparison

The current volatility for First Trust Nasdaq Pharmaceuticals ETF (FTXH) is 5.38%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 11.28%. This indicates that FTXH experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTXHBBCDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.38%

11.28%

-5.90%

Volatility (6M)

Calculated over the trailing 6-month period

11.96%

26.27%

-14.31%

Volatility (1Y)

Calculated over the trailing 1-year period

17.14%

35.44%

-18.30%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.34%

39.32%

-22.98%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.43%

37.74%

-19.31%

FTXH vs. BBC - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is lower than BBC's 0.79% expense ratio.


Dividends

FTXH vs. BBC - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.19%, less than BBC's 1.53% yield.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.53%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.19%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%0.00%

Frequently Asked Questions


FTXH and BBC have a correlation of 0.56, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BBC has higher volatility (11.28%) compared to FTXH (5.38%). In terms of maximum drawdown, FTXH dropped -32.11% vs BBC's -76.85%.

On 5-year performance, FTXH leads with 8.33% vs -1.47% for BBC. On fees, FTXH is cheaper at 0.60% per year. On volatility, FTXH has been the lower-risk option at 5.38%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, FTXH has performed better with a 8.33% return vs -1.47%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

FTXH is cheaper with a 0.60% expense ratio, compared with 0.79% for BBC.

BBC has the higher dividend yield at 1.53%, compared with 1.19% for FTXH.

FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: First Trust and Virtus Investment Partners. Their fees differ too: 0.60% for FTXH and 0.79% for BBC.

BBC currently has the higher Sharpe Ratio (3.49 vs 2.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTXH and BBC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer